Pie Medical Imaging announced its new release of CAAS MRV, for analysis of the heart to support diagnosis of cardiovascular conditions. This new version contains intuitive and guided analysis workflows, optimized to clinical practice. The workflows guide users through the required steps for functional left and right ventricle, viability and first pass perfusion analysis. The new viability workflow includes, besides analysis of delayed enhanced MR (magnetic resonance) images, also analysis of edema on T2-weighted MR images. The combination of segmented infarcts and edema areas can identify the salvageable areas.

electronic Clinical Outcome Assessment (eCOA)

GE Healthcare announced the launch of its new introductory dose management solution, DoseWatch Explore, which is now available on select GE computed tomography (CT) systems in the United States. DoseWatch Explore is a Web-based, cloud-deployed, dose management software that tracks, analyzes and reports practice-level radiation dose data for GE CT systems.

Calgary Scientific Inc. announced the release of ResolutionMD 5.1. The latest software version enables physicians to make faster and more informed treatment decisions, by providing even greater access to medical images and information via Web and mobile devices.

A new magnetic resonance imaging (MRI) study has found distinct injury patterns in the brains of people with concussion-related depression and anxiety, according to a new study published online in the journal Radiology. The findings may lead the way to improved treatment and understanding of these common disorders, researchers said.

IMRIS Inc. received a letter May 26 from the NASDAQ Stock Market stating that it would be delisted and trading suspended on June 4. IMRIS said this was in accordance with Listing Rules 5101, 5110(b), and IM-5101-1. A Form 25-NSE will be filed with the Securities and Exchange Commission (the SEC), which will remove the company's securities from listing and registration on The Nasdaq Stock Market.

Toshiba America Medical Systems Inc. has received U.S. Food and Drug Administration (FDA) clearance for detector and computed tomography (CT) software enhancements for its Aquilion ONE family of CT systems. which are designed to offer customers the right technology to meet their business needs for improving patient safety, have received FDA clearance.

Richardson Electronics, Ltd. today announced the signing of a definitive agreement to acquire the assets of International Medical Equipment and Service, Inc. (IMES). IMES is the first acquisition completed by Richardson Healthcare, the division of Richardson Electronics focused on high-value components and replacement parts for the diagnostic imaging market.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now